# Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma

> **NCT04401267** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 51 (actual)

## Conditions studied

- Hypertension
- Osteonecrosis
- Osteonecrosis Due to Drug

## Interventions

- **DRUG:** Intensive Antihypertensive Therapy
- **DRUG:** Conventional Antihypertensive Therapy
- **OTHER:** Symptom Survey
- **OTHER:** Semi-structured interview

## Key facts

- **NCT ID:** NCT04401267
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2023-09-25
- **Final completion:** 2025-10-07
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04401267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04401267, "Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04401267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*